Intrinsic value of AstraZeneca PLC (AZN)
Live fair value data for AstraZeneca PLC (AZN) is currently unavailable. Please check again shortly.
Current Price: $273.00
Valuation: Undervalued
Confidence: 8.0/10
Visual Bar
This intrinsic value is calculated using 5 different models based on projected revenue growth, profit margins, and a standard discount rate.
Is AstraZeneca PLC (AZN) undervalued or overvalued?
Based on the current model output, AstraZeneca PLC appears to be undervalued with a upside of 46.00%.
Fair value vs market price — AstraZeneca PLC (AZN)
Unlock premium access to view the live fair value comparison against current market price for AZN.
Frequently Asked Questions - AZN
How is AZN intrinsic value estimated?
We combine revenue growth, discount rate, and terminal growth assumptions to estimate a fair value range for AZN.
Is AZN undervalued or overvalued right now?
AZN is currently shown as undervalued based on the difference between market price and intrinsic value.
How should I use the confidence score?
The confidence score (0 to 10) indicates model certainty from available inputs. Higher values suggest stronger model consistency, not a guarantee of returns.
Related companies — intrinsic value
Peers for AZN: open their intrinsic value pages.